The American Journal of Surgery
Volume 198, Issue 4 , Pages 508-510 , October 2009

The identification and treatment of isolated tumor cells reflect disparities in the delivery of breast cancer care

  • Joshua T. Tan, B.S.

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Loma Linda University, Loma Linda, CA, USA
    • ,
  • Melissa Bagnell, B.S.

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Loma Linda University, Loma Linda, CA, USA
    • ,
  • John W. Morgan, Dr.P.H., C.P.H.

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Loma Linda University, Loma Linda, CA, USA
    • Region 5 of the California Cancer Registry, Loma Linda University Medical Center, Loma Linda, CA, USA
    • ,
  • Jan H. Wong, M.D.

      Affiliations

    • Region 5 of the California Cancer Registry, Loma Linda University Medical Center, Loma Linda, CA, USA
    • Department of Surgery, Division of Surgical Oncology, Loma Linda University School of Medicine, 11175 campus St., CP 21111, Loma Linda, CA 92350, USA
    • ,
  • Sharmila Roy-Chowdhury, M.D.

      Affiliations

    • Department of Surgery, Division of Surgical Oncology, Loma Linda University School of Medicine, 11175 campus St., CP 21111, Loma Linda, CA 92350, USA
    • ,
  • Sharon S. Lum, M.D.

      Affiliations

    • Department of Surgery, Division of Surgical Oncology, Loma Linda University School of Medicine, 11175 campus St., CP 21111, Loma Linda, CA 92350, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1-909-558-4286; fax: +1-909-558-0236

Received 23 March 2009 ,Revised 6 July 2009

References 

  1. Cserni G, Gregori D, Merletti F, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg. 2004;91:1245–1252
  2. Pugliese M, Beatty J, Tickman R, et al. Impact and outcomes of routine microstaging of sentinel lymph nodes is breast cancer: singificance of the PNO (it) and PN1mi categories. Ann Surg Oncol. 2009;16:113–120
  3. Colleoni M, Rotmensz N, Peruzzotti G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005;23:1379–1389
  4. Pugliese M, Bealty J, Tickman R, et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer, significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol. 2009;16:113–120
  5. Chagpar A, Middleton LP, Sahin AA, et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer. 2005;103:1581–1586
  6. Rutgers EJ. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol. 2008;26:698–702
  7. Yost K, Perkins C, Cohen R, et al. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12:703–711
  8. Newman LA, Martin IK. Disparities in breast cancer. Curr Probl Cancer. 2007;31:134–156
  9. Gilligan MA, Neuner J, Zhang X, et al. Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. Am J Public Health. 2007;97:539–544
  10. Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol. 2008;26:3338–3345

PII: S0002-9610(09)00374-2

doi: 10.1016/j.amjsurg.2009.07.001

The American Journal of Surgery
Volume 198, Issue 4 , Pages 508-510 , October 2009

Article Tools